<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee JJY</submitter><funding>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</funding><funding>EIF | Stand Up To Cancer (SU2C)</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</funding><funding>NCI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Wellcome Trust</funding><pagination>88-102</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11735403</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>57(1)</volume><pubmed_abstract>Transcription factors are frequent cancer driver genes, exhibiting noted specificity based on the precise cell of origin. We demonstrate that ZIC1 exhibits loss-of-function (LOF) somatic events in group 4 (G4) medulloblastoma through recurrent point mutations, subchromosomal deletions and mono-allelic epigenetic repression (60% of G4 medulloblastoma). In contrast, highly similar SHH medulloblastoma exhibits distinct and diametrically opposed gain-of-function mutations and copy number gains (20% of SHH medulloblastoma). Overexpression of ZIC1 suppresses the growth of group 3 medulloblastoma models, whereas it promotes the proliferation of SHH medulloblastoma precursor cells. SHH medulloblastoma ZIC1 mutants show increased activity versus wild-type ZIC1, whereas G4 medulloblastoma ZIC1 mutan</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.</pubmed_title><pmcid>PMC11735403</pmcid><funding_grant_id>R01 CA255369</funding_grant_id><funding_grant_id>SU2C-AACR-DT1113</funding_grant_id><funding_grant_id>SU2C-AACR-DT-19-15</funding_grant_id><funding_grant_id>R01 CA159859</funding_grant_id><funding_grant_id>R01NS106155</funding_grant_id><funding_grant_id>1R01CA270785-01A1</funding_grant_id><funding_grant_id>R37 NS095733</funding_grant_id><funding_grant_id>R01 CA270785</funding_grant_id><funding_grant_id>R01CA255369</funding_grant_id><funding_grant_id>P01 CA096832</funding_grant_id><funding_grant_id>R01 NS106155</funding_grant_id><pubmed_authors>Mount CW</pubmed_authors><pubmed_authors>Morrissy S</pubmed_authors><pubmed_authors>Kool M</pubmed_authors><pubmed_authors>Suva ML</pubmed_authors><pubmed_authors>Livingston BG</pubmed_authors><pubmed_authors>French PJ</pubmed_authors><pubmed_authors>Hendriske LD</pubmed_authors><pubmed_authors>Das Gupta N</pubmed_authors><pubmed_authors>Korshunov A</pubmed_authors><pubmed_authors>Phillips JJ</pubmed_authors><pubmed_authors>Thompson RC</pubmed_authors><pubmed_authors>Kros JM</pubmed_authors><pubmed_authors>Perek-Polnik M</pubmed_authors><pubmed_authors>Batts M</pubmed_authors><pubmed_authors>Visvanathan A</pubmed_authors><pubmed_authors>Kim SK</pubmed_authors><pubmed_authors>Wu X</pubmed_authors><pubmed_authors>Zadeh G</pubmed_authors><pubmed_authors>Taylor MD</pubmed_authors><pubmed_authors>Saad AG</pubmed_authors><pubmed_authors>Northcott PA</pubmed_authors><pubmed_authors>Garzia L</pubmed_authors><pubmed_authors>Gallo M</pubmed_authors><pubmed_authors>Bendel A</pubmed_authors><pubmed_authors>Abeysundara N</pubmed_authors><pubmed_authors>Cavalli FMG</pubmed_authors><pubmed_authors>Palotta J</pubmed_authors><pubmed_authors>Bailey S</pubmed_authors><pubmed_authors>Grajkowska WA</pubmed_authors><pubmed_authors>Lee JJY</pubmed_authors><pubmed_authors>Tominaga T</pubmed_authors><pubmed_authors>Ra YS</pubmed_authors><pubmed_authors>Huang LF</pubmed_authors><pubmed_authors>Weiss WA</pubmed_authors><pubmed_authors>Mack SC</pubmed_authors><pubmed_authors>Singh SK</pubmed_authors><pubmed_authors>Klekner A</pubmed_authors><pubmed_authors>Farooq H</pubmed_authors><pubmed_authors>Michealraj KA</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Ramaswamy V</pubmed_authors><pubmed_authors>Suzuki H</pubmed_authors><pubmed_authors>Wang EY</pubmed_authors><pubmed_authors>Lupien M</pubmed_authors><pubmed_authors>Richman CM</pubmed_authors><pubmed_authors>Bognar L</pubmed_authors><pubmed_authors>Kenney AM</pubmed_authors><pubmed_authors>Haldipur P</pubmed_authors><pubmed_authors>Loukides J</pubmed_authors><pubmed_authors>Fong V</pubmed_authors><pubmed_authors>Pollack IF</pubmed_authors><pubmed_authors>Jabado N</pubmed_authors><pubmed_authors>Cho BK</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Millen KJ</pubmed_authors><pubmed_authors>Cooper MK</pubmed_authors><pubmed_authors>Hadley J</pubmed_authors><pubmed_authors>Lach B</pubmed_authors><pubmed_authors>Luu B</pubmed_authors><pubmed_authors>Suarez R</pubmed_authors><pubmed_authors>Daniels C</pubmed_authors><pubmed_authors>Erickson AW</pubmed_authors><pubmed_authors>Lee JY</pubmed_authors><pubmed_authors>Wang KC</pubmed_authors><pubmed_authors>Dai S</pubmed_authors><pubmed_authors>Rasnitsyn A</pubmed_authors><pubmed_authors>Leary SES</pubmed_authors><pubmed_authors>Chico Ponce de Leon F</pubmed_authors><pubmed_authors>Hamilton RL</pubmed_authors><pubmed_authors>Tao R</pubmed_authors><pubmed_authors>Perezpena-Diazconti M</pubmed_authors></additional><is_claimable>false</is_claimable><name>ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.</name><description>Transcription factors are frequent cancer driver genes, exhibiting noted specificity based on the precise cell of origin. We demonstrate that ZIC1 exhibits loss-of-function (LOF) somatic events in group 4 (G4) medulloblastoma through recurrent point mutations, subchromosomal deletions and mono-allelic epigenetic repression (60% of G4 medulloblastoma). In contrast, highly similar SHH medulloblastoma exhibits distinct and diametrically opposed gain-of-function mutations and copy number gains (20% of SHH medulloblastoma). Overexpression of ZIC1 suppresses the growth of group 3 medulloblastoma models, whereas it promotes the proliferation of SHH medulloblastoma precursor cells. SHH medulloblastoma ZIC1 mutants show increased activity versus wild-type ZIC1, whereas G4 medulloblastoma ZIC1 mutan</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-01T21:07:11.98Z</modification><creation>2025-04-06T01:16:03.978Z</creation></dates><accession>S-EPMC11735403</accession><cross_references><pubmed>39753768</pubmed><doi>10.1038/s41588-024-02014-z</doi></cross_references></HashMap>